Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | BARD1 |
| Variant | S142* |
| Impact List | nonsense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | BARD1 S142* results in a premature truncation of the Bard1 protein at amino acid 142 of 777 (UniProt.org). S142* has not been biochemically characterized however, due to the effects of other truncation mutations downstream of S142 (PMID: 31371347, PMID: 30925164), is predicted to lead to a loss of Bard1 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
BARD1 mutant BARD1 inact mut BARD1 S142* |
| Transcript | NM_000465.4 |
| gDNA | chr2:g.214781449G>T |
| cDNA | c.425C>A |
| Protein | p.S142* |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_017004613.1 | chr2:g.214792334_214792336delAGTinsTGA | c.424_426delAGTinsTGA | p.S142* | RefSeq | GRCh38/hg38 |
| XM_017004614.1 | chr2:g.214792334_214792336delAGTinsTGA | c.424_426delAGTinsTGA | p.S142* | RefSeq | GRCh38/hg38 |
| XM_017004613 | chr2:g.214792334_214792336delACTinsTCA | c.424_426delAGTinsTGA | p.S142* | RefSeq | GRCh38/hg38 |
| NM_000465 | chr2:g.214781449G>T | c.425C>A | p.S142* | RefSeq | GRCh38/hg38 |
| XM_047445350.1 | chr2:g.214781449G>T | c.425C>A | p.S142* | RefSeq | GRCh38/hg38 |
| XM_017004614 | chr2:g.214792334_214792336delACTinsTCA | c.424_426delAGTinsTGA | p.S142* | RefSeq | GRCh38/hg38 |
| XM_017004614.2 | chr2:g.214792334_214792336delAGTinsTGA | c.424_426delAGTinsTGA | p.S142* | RefSeq | GRCh38/hg38 |
| NM_000465.3 | chr2:g.214781449G>T | c.425C>A | p.S142* | RefSeq | GRCh38/hg38 |
| NM_000465.4 | chr2:g.214781449G>T | c.425C>A | p.S142* | RefSeq | GRCh38/hg38 |
| XM_017004613.2 | chr2:g.214792334_214792336delAGTinsTGA | c.424_426delAGTinsTGA | p.S142* | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|